Figure 3.

Detection of pro-inflammatory factors (MIP1β and MCP1) in the serum of melanoma patients. Serum from melanoma patients was collected at different time points: baseline, 2 hours, 1 month and 2 months post-treatments. The presence in the serum of macrophage chemoattractant protein 1 (MCP-1) and macrophage inflammatory protein 1β (MIP-1β) was assessed by ELISA. Data represent pg/mL of each soluble factor. Statistical analysis of differences between means of soluble factors was performed by 2-tailed Student's t-test with significance defined as p < 0.05.